STOCK TITAN
  1. Home
  2. Sec-filings
  3. ESQ
  4. [Form 4] Esquire Financial Holdings, Inc. Insider Trading Activity

Esquire Financial (ESQ) CFO logs 300-share stock disposition at $104.04

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Esquire Financial Holdings, Inc.'s senior vice president and chief financial officer reported a transaction in the company's common stock dated December 9, 2025. The filing shows a disposition of 300 shares of common stock, coded "F", at a price of $104.04 per share.

After this transaction, the officer beneficially owns 18,612 shares of common stock directly, which include restricted stock awards vesting in three equal annual installments commencing on December 19, 2023, December 16, 2024, December 9, 2025, December 19, 2026, December 15, 2027, and January 30, 2028, and 1,500 shares indirectly through an IRA. The officer also holds stock options covering 1,500 shares at an exercise price of $24.9 and four grants of 2,500 shares each at exercise prices of $20.85, $31.04, $42.3, and $48.32, with expiration dates on December 10, 2028, December 16, 2030, December 9, 2031, December 19, 2032, and December 15, 2033.

Positive

  • None.

Negative

  • None.
Insider Lacapria Michael
Role SVP & Chief Financial Officer
Type Security Shares Price Value
Tax Withholding Common Stock 300 $104.04 $31K
holding Stock Options -- -- --
holding Stock Options -- -- --
holding Stock Options -- -- --
holding Stock Options -- -- --
holding Stock Options -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 18,612 shares (Direct); Stock Options — 1,500 shares (Direct); Common Stock — 1,500 shares (Indirect, By IRA)
Footnotes (1)
  1. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2023. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027. Includes shares of restricted stock which vest in three equal annual installments commencing on January 30, 2028. Stock options are fully vested. Stock options vest in three equal annual installments commencing on December 19, 2023. Stock options vest in three equal annual installments commencing on December 15, 2024.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lacapria Michael
(Last) (First) (Middle)
100 JERICHO QUADRANGLE
SUITE 100
(Street)
JERICHO NY 11753
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Esquire Financial Holdings, Inc. [ ESQ ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP & Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/09/2025 F 300 D $104.04 18,612(1)(2)(3)(4)(5)(6) D
Common Stock 1,500 I By IRA
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options $24.9 12/10/2019 12/10/2028 Common Stock 1,500(7) 1,500(7) D
Stock Options $20.85 12/16/2021 12/16/2030 Common Stock 2,500(7) 2,500(7) D
Stock Options $31.04 12/09/2022 12/09/2031 Common Stock 2,500(7) 2,500(7) D
Stock Options $42.3 12/19/2023 12/19/2032 Common Stock 2,500(8) 2,500(8) D
Stock Options $48.32 12/15/2024 12/15/2033 Common Stock 2,500(9) 2,500(9) D
Explanation of Responses:
1. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2023.
2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.
3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.
4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.
5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.
6. Includes shares of restricted stock which vest in three equal annual installments commencing on January 30, 2028.
7. Stock options are fully vested.
8. Stock options vest in three equal annual installments commencing on December 19, 2023.
9. Stock options vest in three equal annual installments commencing on December 15, 2024.
/s/ Eric S. Bader, pursuant to power of attorney 12/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider stock transaction did Esquire Financial (ESQ) disclose?

The filing reports that the company's senior vice president and chief financial officer disposed of 300 shares of Esquire Financial common stock on December 9, 2025 at $104.04 per share, coded "F."

How many ESQ shares does the reporting officer own after the December 9, 2025 transaction?

Following the reported transaction, the officer beneficially owns 18,612 shares of Esquire Financial common stock directly and 1,500 shares indirectly through an IRA.

What restricted stock awards are noted for the Esquire Financial officer?

The beneficial ownership includes restricted stock that vests in three equal annual installments commencing on December 19, 2023, December 16, 2024, December 9, 2025, December 19, 2026, December 15, 2027, and January 30, 2028.

What stock options in ESQ does the reporting person hold?

The officer holds stock options covering 1,500 shares at an exercise price of $24.9 and four additional grants of 2,500 shares each at exercise prices of $20.85, $31.04, $42.3, and $48.32, with expirations between December 10, 2028 and December 15, 2033.

What is the reporting person’s relationship to Esquire Financial (ESQ)?

The reporting person is an officer of Esquire Financial Holdings, Inc., serving as Senior Vice President & Chief Financial Officer.